Medicine guide

Simulect 20 mg

As listed in the register: Simulect 20 mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung

20 mg ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Basiliximabum
Made by
Novartis Pharma Schweiz AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Nierentransplantation

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byNovartis Pharma Schweiz AG
Active substanceBasiliximabum
Used inCancer treatments and immune-system medicines
Strength20 mg
ClassificationL04AC02 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerSimulect 20 mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Packs1 + 1 Ampulle(n)
Zulassungsnummer54630
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.